This site is intended for health professionals only
Thursday 29 September 2016 Instagram
Share |

Cervical cancer jab uptake increases

Cervical cancer jab uptake increases

Over 84% of girls aged 13-14 have helped protect themselves against cervical cancer by getting all three doses of the HPV vaccine and more than four million doses of the vaccine have been given in the first two years of the programme, Public Health Minister, Anne Milton, announced today.

The latest figures reveal that the programme is one of the most successful in the world with over 76% of girls aged 12-13 having had the full three doses of the vaccine in the second year of the programme with more expected to do so.

New statistics out today show:

  • 84.1% of girls in the first routine cohort (now aged 13-14 years) have now had the full course of vaccine
  • 76.4% of girls in the second routine cohort (aged 12-13 years) have so far completed the vaccination course in 2009-10 with more expected to do so
  • The earlier than planned introduction of catch up campaigns for girls aged 14-18 in 2009 meant that the NHS was able to begin protecting more girls sooner
  • In total 60.4% of all 12-19 year olds have had the full course.

These figures are already more than twice as high as figures for similar aged girls in the US programme.

Public Health Minister, Anne Milton, said: "Being able to help protect young women against this disease is a fantastic development and the uptake is very encouraging.

“But we can always do more. This vaccination reduces the risk of cervical cancer and will save up to 400 deaths every year in the UK. I would ask every girl between 12 and 18 who has not considered vaccination or who has not completed the full course to speak to their school or GP – all three doses are needed for full protection.”

Director of Jo’s Cervical Cancer Trust, Robert Music, said: “It is encouraging to see that many girls are getting vaccinated against HPV but we would like to see this increase further. We must remind girls that they are eligible for vaccination up to 18 years and I urge everyone who has yet to take part in this potentially life saving programme to do so.

“Research has shown that if uptake is 80% year on year we could see a two-thirds reduction in cervical cancer incidence in women under 30 by 2025 and I cannot see any greater incentive to do all we can to ensure as many young women as possible are vaccinated.”

DH

Ads by Google

You are leaving www.nursinginpractice.com

You are currently leaving the Nursing in Practice site. Are you sure you want to proceed?